Clinical Trial Update: Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing bosutinib-letrozole combination versus letrozole alone in postmenopausal breast cancer; study terminated with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bosutinib (bosutinib)
• Letrozole (letrozole)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-11-05